Ventura, Ilana M.
Zhong, Selena
Bilgen, Ipek
Dutwin, David
Delgado, Jane L.
Funding for this research was provided by:
Healthy Americas Foundation
Article History
Received: 20 August 2021
Accepted: 12 November 2021
First Online: 29 November 2021
Declarations
:
: This work is supported in part by Hologic, Inc., who did not have any role in the study design, collection, analysis, interpretation of data, writing the report, or the decision to submit the report for publication. Jane L. Delgado supervised the study and commissioned the project from NORC on behalf of the Healthy Americas Foundation and the National Alliance for Hispanic Health. Jane Delgado is Vice Chair of Lovelace Biomedical Research Institute, on the Board of Governors of Argonne National Labs, and is the President and CEO of Healthy Americas Foundation and the National Alliance for Hispanic Health. Questionnaire and methodology approval was granted by the Institutional Review Board (IRB) at NORC at the University of Chicago. The research was carried out following the guidelines of the NORC IRB, in accordance with U.S. Department of Health and Human Services regulations. NORC’s IRB is registered with the Federal Office for Human Research Protections. Informed consent was obtained from all individual participants included in the survey.